High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

BACKGROUND: Maintaining health-related quality of life (HRQoL) is highly desirable during systemic therapies for patients with castration-resistant prostate cancer (CRPC). Patient-reported outcome measures (PROs) were studied in our phase IIa trial on cellular-based immunotherapy with dendritic cell...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Westdorp, Harm, Creemers, Jeroen H. A., van Oort, Inge M., Mehra, Niven, Hins-de Bree, Simone M., Figdor, Carl G., Witjes, J. Alfred, Schreibelt, Gerty, de Vries, I. Jolanda M., Gerritsen, Winald R., Ottevanger, Petronella B.
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649342/
https://ncbi.nlm.nih.gov/pubmed/33194595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.536700
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы